Media

Event
Medical
Corporate
Medical
2019-05-10

Fight Cancer With NGS !Authority in Lung Cancer Use CGP To Defeat Cancer

Chun-Ming Tsai, Consultant Physician Taipei Veterans General Hospital cooperates with ACT Genomics to use ACTDrug+ & ACTMonitor to assist 202 patients to fight cancer successfully

Published:

Taipei

Author(s):

Health News

Corporate
2019-04-19

ACT Genomics Establishes NGS Laboratory to Offer Comprehensive Cancer Genomic Profiling Service in Japan

More precision cancer medicine are available for clinical needs and drug development in Japan! Find out more at the new analysis laboratory "Shonan iPark Laboratory" of ACTmed, a joint venture between Canon Medical Systems and ACT Genomics in Japan.

Published:

Taipei

Author(s):

PRWire

Corporate
2018-12-06

ACT Genomics joins TMB Harmonization Project

TMB (tumor mutational burden) is an important biomarker for predicting immunotherapy response. The project convened major diagnostics company to standardize TMB calculation across tests. ACT Genomics is the only non-US company participating in the project

Published:

Author(s):

Corporate
2018-10-09

ACT Genomics Finished A New Fundraising Round in The Wave of Medical Market Growth

Global medical market grows at the rate of 7% steadily, and the compound annual growth rate is expected to reach 19% in 2030 with the explosive potential in precision medicine. ACT Genomics Holdings Company Limited focusing on cancer genomic profiling se

Published:

Taipei

Author(s):

Medical
2018-09-21

Finding New Drug through Cancer Genomic Profiling is The New Option for Cancer Treatment

A patient with advanced colon cancer was eager to find new drugs through comprehensive cancer genomic profiling, and two targeted drugs were used to control cancer growth.

Published:

Taipei

Author(s):

PChome online

Event
2018-09-06

Hong Kong is Actively Building Technology Platform

Mr. Eddie Liu, Managing Director of ACT Genomics Hong Kong was invited to give a talk to share the experience of ACT Genomics expanding from Taiwan to Hong Kong.

Published:

Taipei

Author(s):

China Times

Event
2018-08-27

The Trend Toward Intelligent Biomedical Industry – Taipei Biotechnology Industry Summit

The Taipei Biotechnology Industry Summit was held in Taipei on August 27th by Department of Economic Development, Taipei City Government. ACT Genomics CEO, Dr. Hua-Chien Chen shared ”cancer precision medicine and its clinical application”. Dr. Chen said

Published:

Taipei

Author(s):

Global Monthly

Event
2018-06-15

ACT Genomics Shared Cutting-Edge Technology in Taiwan Bio Forum

ACT Genomics was invited to Taiwan Bio Forum, which was held in Harvard Medical School in USA this year. As the first speaker, ACT Genomics shared cutting-edge technology application in cancer management and precision medicine.

Published:

Author(s):

Economic Daily News

Event
2018-06-06

Taiwan Bio Forum on digital transformation in healthcare

ACT Genomics is honoured to introduce precision medicine in Taiwan Bio Forum co-organized by The Development Center for Biotechnology (DCB) and Monte Jade Science and Technology Association of New England (MJNE) in Boston.

Published:

Author(s):

United Daily

Corporate
2018-06-05

Clinical Utility of and Access to Cancer Molecular Diagnostics in Asia

ACT Genomics Singapore is honoured to be featured in Asia-Pacific Biotech News (APBN) magazine June 2018 issue, with features article titled “Clinical Utility of and Access to Cancer Molecular Diagnostics in Asia”. Dr Allen Lai & Dr Liisa sharing how mole

Published:

Author(s):